Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation

Clinical trial NCT00248040 · COMPLETED

Trial details

NCT number: NCT00248040
Sponsor: Dompé Farmaceutici S.p.A
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemia-Reperfusion Injury Kidney Diseases

Start date: 2005-10-01
Primary completion: 2008-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.